Schedule 13G ownership disclosure

RVL PHARMACEUTICALS PLC

Security class unavailable · CUSIP: G6S41R101

Event date: 2020-11-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,936,926
Percent of class
7.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001554795-20-000313
Form type
SC 13G
Filer
Orbit Co-Invest I LLC
CIK
CIK 1751055
Filed
Nov 27, 2020
Reporting period
Nov 20, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub